KRAS and neoplasm: Furthermore, Myc depletion led to increased expression of IFN signaling molecules, which were not further upregulated upon treatment with MEKi (Supplementary Fig. S3F), suggesting that oncogenic KRAS suppresses tumor-intrinsic IFN responses by driving expression of Myc.